46,XX DSD (Disorder of Sex Development)
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
46,XX DSD (Disorder of Sex Development) is a condition where a person has two X chromosomes but their reproductive or sexual anatomy does not develop typically. This condition affects the reproductive system, leading to differences in the appearance of the external genitalia or internal reproductive organs. People with this condition may have ambiguous genitalia or features that do not clearly match typical male or female anatomy. It can also impact hormone levels and fertility. The condition is usually present from birth and can be caused by variations in genes or hormone production. Diagnosis often involves physical exams and specialized tests. Understanding this condition helps explain why some individuals have differences in sexual development.
Clinical Definition
46,XX DSD refers to a group of congenital conditions characterized by a discrepancy between chromosomal, gonadal, or anatomical sex in individuals with a 46,XX karyotype. The core pathology involves atypical development of the external genitalia due to abnormal androgen exposure or synthesis during fetal development. The most common cause is congenital adrenal hyperplasia (CAH), typically due to 21-hydroxylase deficiency, leading to excess androgen production by the adrenal glands. Other causes include maternal androgen exposure or rare enzyme defects affecting steroidogenesis. Clinically, affected individuals may present with ambiguous genitalia, virilization, or normal female internal reproductive structures. This condition is significant because it affects gender assignment, fertility potential, and requires careful endocrine and genetic evaluation. Early diagnosis and management are critical to address hormonal imbalances and guide appropriate care.